Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,020.00    -110.00 (-1.54%)
Bid:
7,010.00
Ask:
7,020.00
Spread: 10.00 (0.143%)
Market Cap: £9.41b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Trading Statement

17 Mar 2011 07:00

RNS Number : 0949D
Diploma PLC
17 March 2011
Β 

ο»Ώ

Β 

DIPLOMAΒ PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

Β 

FOR IMMEDIATE RELEASE

Β 

17 March 2011

Β 

Β 

Β 

DIPLOMA PLC

Β 

TRADING UPDATE

Β 

Β 

Diploma PLC, the international group of businesses supplying specialised technical products and services, is today issuing a trading update, ahead of going into close period at 31 March 2011.

Β 

Trading

The strong increase in both revenues and profitability reported in the first quarter has continued through the second quarter, boosted by strong contributions from acquired businesses. Group revenues in the six months ended 31 March 2011 are expected to be ca. 25% ahead of the comparable period in FY2010 and underlying revenues, after adjusting for currency effects and acquisitions, are likely to increase by ca. 16% against the comparable period last year.

Β 

The increase in revenues has been achieved while still maintaining tight control of operating costs and operating margins have further improved in each of the Group's three sectors. The combination of increasing revenue and margins will result in a significant increase in operating profit in the six months ending 31 March 2011, compared to the comparable period last year, part of which suffered from the impact of the economic downturn.

Β 

Subject to there being no significant changes in the major economies, the Directors expect continuing strength in revenues and operating margins across the Group's businesses and that the Group's adjusted profit before tax* for the year ending 30 September 2011 will be materially ahead of the current market consensus of Β£36.3m.

Β 

Acquisitions

As indicated in the IMS issued on 12 January 2011, pursuant to the Sale and Purchase Agreement dated 28 July 2007 for the acquisition of AMT Vantage Inc, the Group has now completed the acquisition of all of the outstanding shares from the minority shareholders for aggregate consideration of Β£12.3m (C$19.5m). Together with the acquisition of Carsen Medical Inc. in December 2010, the Group has invested a total of Β£27.5m during the half year in acquiring businesses.

Β 

Financial Position

The continuing strong trading activity, together with a return to the more normal seasonal historic trends in working capital, has contributed to a significant increase in working capital in the first half of the year. Following the payment of dividends to shareholders, including payments to minority shareholders, the Group expects to have net debt of ca. Β£5m at 31 March 2011. In the second half of the year, the Group expects to generate strong free cash flow, which subject to further acquisition expenditure, should result in the Group having net cash funds at 30 September 2011.

Β 

The Directors will provide a further update on trading prospects for the year on Tuesday, 17 May 2011, as part of their announcement of the Group's results for the six months year ending 31 March 2011.

Β 

Β 

Β 

*

Β 

Adjusted profit before tax is defined as profit before tax and before the costs of restructuring or rationalisation of operations, the profit or loss relating to the sale of property or businesses, fair value remeasurements under IAS 32 and IAS 39 in respect of future purchases of minority interests and acquisition related charges, as set out in the Group's FY2010 Annual Report.

Β 

Β 

Β 

Notes:

Β 

1. A copy of this Statement, together with further information about Diploma PLC, may be viewed on its website at www.diplomaplc.com

Β 

Β 

Β 

For further enquiries please contact:

Bruce Thompson, Chief Executive Officer

020 7549 5700

Nigel Lingwood, Group Finance Director

020 7549 5705

Simon Bloomfield, Bankside Consultants

020 7367 8861

Β 

Β 

Β 

Β 

Β 

NOTE TO EDITORS:

Β 

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

Β 

Diploma achieves stable growth and attractive margins from its focus on supplying specialised technical products to markets which value high levels of customer service, technical support and value adding activities. A high proportion of revenues are generated from essential products and services funded by operating, rather than capital budgets.

Β 

The Group employs ca. 875 employees and its principal operating businesses are located in the UK, Germany, US and Canada.

Β 

Over the last five years, the Group has grown adjusted earnings per share at an average of ca. 14% p.a. through a combination of organic growth and acquisitions. The current market capitalisation is ca. Β£305m.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTGGUQAWUPGGQQ
Date   Source Headline
9th Apr 201410:09 amRNSHolding(s) in Company
25th Mar 20149:48 amRNSDirector/PDMR Shareholding
24th Mar 20147:00 amRNSTrading Statement
26th Feb 20144:18 pmRNSHolding(s) in Company
12th Feb 20144:09 pmRNSHolding(s) in Company
5th Feb 20144:55 pmRNSHolding(s) in Company
31st Jan 201410:23 amRNSHolding(s) in Company
16th Jan 201411:00 amRNSHolding(s) in Company
15th Jan 20145:04 pmRNSResolutions of AGM
15th Jan 20147:00 amRNSInterim Management Statement
9th Dec 20134:20 pmRNSDirector/PDMR Shareholding
9th Dec 20134:10 pmRNSDirector/PDMR Shareholding
6th Dec 20137:00 amRNSAnnual Financial Report and Notice of AGM
22nd Nov 20132:00 pmRNSDirector/PDMR Shareholding
18th Nov 201311:21 amRNSAppointment of Director
18th Nov 20137:00 amRNSPreliminary Announcement of Results
4th Nov 20134:40 pmRNSSecond Price Monitoring Extn
4th Nov 20134:35 pmRNSPrice Monitoring Extension
1st Oct 201310:00 amRNSDirectorate Change
26th Sep 20137:00 amRNSTrading Statement
10th Sep 20137:00 amRNSInvestor Event
30th Jul 20137:00 amRNSInterim Management Statement
29th Jul 20134:00 pmRNSBoard Committee Changes
23rd Jul 20132:00 pmRNSHolding(s) in Company
25th Jun 201310:15 amRNSDirector/PDMR Shareholding
17th Jun 201311:30 amRNSHolding(s) in Company
30th May 20137:00 amRNSAppointment of Non-Executive Directors
15th May 20138:05 amRNSDirector/PDMR Shareholding
13th May 20137:00 amRNSHalf Yearly Report
19th Apr 20137:00 amRNSNotice of Results
2nd Apr 20134:00 pmRNSDirector Declaration
25th Mar 20137:00 amRNSTrading Statement
22nd Mar 20139:42 amRNSBoard Committee Change
14th Mar 201312:00 pmRNSEmployee Benefit Trust Dealings
21st Jan 20132:21 pmRNSDirector/PDMR Shareholding
16th Jan 20134:35 pmRNSResult of AGM
16th Jan 20137:00 amRNSInterim Management Statement
20th Dec 20124:11 pmRNSDirector/PDMR Shareholding
19th Dec 201210:56 amRNSDirector/PDMR Shareholding
10th Dec 20121:47 pmRNSAnnual Financial Report and Notice of AGM
21st Nov 20124:00 pmRNSDirector/PDMR Shareholding
19th Nov 20127:00 amRNSPreliminary Announcement
14th Nov 20127:00 amRNSAppointment of Non-Executive Director
24th Sep 20127:00 amRNSPre-Close Update
21st Sep 20121:24 pmRNSHolding(s) in Company
21st Sep 20127:00 amRNSCompany Secretary Change
10th Aug 20123:30 pmRNSDirector/PDMR Shareholding
30th Jul 20127:00 amRNSInterim Management Statement
5th Jul 20124:00 pmRNSHolding(s) in Company
14th May 201211:37 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.